Positive Charge-Concentrated Dimeric Lipopeptides with Enhanced Protease Resistance: A Potential Solution for Systemic Bacterial Infections
Journal of Medicinal Chemistry · 23.01.2025 · 68 (2) · 1397-1416
DOI: 10.1021/acs.jmedchem.4c01966 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, online erschienen am 01.01.2025. Verfasst von Xi Yan und 8 weiteren Autor:innen. Beteiligte Einrichtung: College of Animal Science and Technology, Northeast Agricultural University, Harbin 150030, People's Republic of China. Hauptthemen laut MEDLINE: Lipopeptides, Anti-Bacterial Agents, Microbial Sensitivity Tests. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 69 Literaturangaben. Gefördert von: National Key Research and Development Program of China, National Natural Science Foundation of China, Heilongjiang Provincial Collaborative Innovation Achievement Project for Universities?Incubation Project.
Abstract (Originalsprache)
Antimicrobial peptides (AMPs) show potential as antibiotic alternatives for bacterial infections; nevertheless, the susceptibility to proteases limits their broader utilization. This study developed engineered lipopeptides using antienzymolysis modifications and cysteine (Cys)-dimerization strategy. As the key parameters for the functioning of AMPs, hydrophobicity and positive charges were concentrated within the peptide sequence by adjusting the intermolecular disulfide bond placement to study their distribution effects. Their centralization in the sequence induces a differential propensity of engineered lipopeptides toward bacterial membranes. Positive charge-concentrated dimeric lipopeptide (C-C10)C-C displayed strong resistance to various proteases, and demonstrated excellent stability and activity in vitro, effectively eliminating systemic bacterial infections in mice without eliciting in vivo toxicity. The bactericidal effects of (C-C10)C-C were achieved through a synergistic mechanism involving membrane cleavage and the inhibition of energy metabolism. In summary, these advances offered valuable insights into enhancing the protease resistance of AMPs and the potential for modifying peptide-based biomaterials through Cys-dimerization.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- College of Animal Science and Technology, Northeast Agricultural University, Harbin 150030, People's Republic of China.
ORCID-Profile: Xi Yan, Chengyi Yang, Anshan Shan
Förderung
- National Key Research and Development Program of China
- National Natural Science Foundation of China
- Heilongjiang Provincial Collaborative Innovation Achievement Project for Universities?Incubation Project
Zitieren
APA
Yan, X., Yang, C., Li, B., Bian, Y., Yu, W., Zhu, Y., Cheng, B., Lyu, Y., & Shan, A. (2025). Positive Charge-Concentrated Dimeric Lipopeptides with Enhanced Protease Resistance: A Potential Solution for Systemic Bacterial Infections. Journal of Medicinal Chemistry, 68(2), 1397-1416. https://doi.org/10.1021/acs.jmedchem.4c01966
Vancouver
Yan X, Yang C, Li B, Bian Y, Yu W, Zhu Y, et al. Positive Charge-Concentrated Dimeric Lipopeptides with Enhanced Protease Resistance: A Potential Solution for Systemic Bacterial Infections. Journal of Medicinal Chemistry. 2025;68(2):1397-1416. doi:10.1021/acs.jmedchem.4c01966
BibTeX
@article{Yan2025,
author = {Yan, Xi and Yang, Chengyi and Li, Bo and Bian, Yifeng and Yu, Weikang and Zhu, Yongjie and Cheng, Baojing and Lyu, Yinfeng and Shan, Anshan},
title = {Positive Charge-Concentrated Dimeric Lipopeptides with Enhanced Protease Resistance: A Potential Solution for Systemic Bacterial Infections},
journal = {Journal of Medicinal Chemistry},
year = {2025},
volume = {68},
number = {2},
pages = {1397--1416},
doi = {10.1021/acs.jmedchem.4c01966}
}
EUVIMED